Want to join the conversation?
$LB expects 4Q15 EPS of $1.85-1.95. For 2015, $LB lifted adjusted EPS guidance to $3.69-3.79 from prior forecast of $3.58-3.73, which incorporates 3Q15 earnings beat to prior forecast and rose 4Q15 interest expense of about $0.04 per share related to its recent $1Bil note issuance. The full-year forecast includes negative FX impact of about $0.12.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?